Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma

NCT02371746 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma and Ocular Hypertension

Interventions

DRUG: ENV515-3 Travoprost XR
DRUG: ENV515-1 Travoprost XR
DRUG: ENV515-3-2 Travoprost XR

Sponsor

Envisia Therapeutics